| 不同部位注射益赛普治疗强直性脊柱炎局部皮肤反应的观察 |
| 投稿时间：2013-09-25 修订日期：2014-06-18 点此下载全文 |
| 引用本文：周付华.不同部位注射益赛普治疗强直性脊柱炎局部皮肤反应的观察[J].药学实践杂志,2015,33(1):72~72,87 |
| 摘要点击次数: 1086 |
| 全文下载次数: 66 |
|
|
| 中文摘要:目的 观察不同部位注射益赛普治疗强直性脊柱炎局部皮肤反应。方法 选取2012年3月-2013年3月在该院住院治疗的强直性脊柱炎患者60例。随机分为A、B两组,每组30例。A组采用上臂三角肌皮下注射,B组采用腹部皮下注射,比较两组患者发生皮肤局部不良反应情况。结果 上臂三角肌皮下注射的A组患者发生不良反应为10例,经腹部皮下注射的B组患者发生不良反应为1例,腹部皮下注射不良反应发生率明显低于上臂三角肌皮下注射(P<0.05)。结论 腹部皮下注射益赛普治疗强直性脊柱炎可以减少局部皮肤的不良反应,提高临床疗效,值得推广应用。 |
| 中文关键词:益赛普 皮下注射 不良反应 |
| |
| Clinical observation on local reaction of the subcutaneous etanercept for treating ankylosing spondylitis with different injection site |
|
|
| Abstract:Objective To observe adverse reactions of the subcutaneous etanercept with different injection site. Methods 60 patients with ankylosing spondylitis treated in our hospital from March 2012 to March 2013 were divided randomly into two groups.A group were injected deltoid subcutaneous,and B group were injected abdominal subcutaneous.The local adverse skin reactions were compared between the two groups. Results 10 cases occurred adverse reactions from A group,and only 1case occurred adverse reactions from group B.The incidence of adverse reactions of injected subcutaneously significantly lower than deltoid subcutaneous (P<0.05). Conclusion Abdominal subcutaneous etanercept could reduces the incidence of adverse reactions,which was worthy of clinical application. |
| keywords:etanercept subcutaneously adverse reaction |
| 查看全文 查看/发表评论 下载PDF阅读器 |
|
| 关闭 |
